LEX Diagnostics
Ian S. currently serves as Principal Scientist at LEX Diagnostics, a position held since March 2023. Prior to this role, Ian S. worked at PA Consulting Group from May 2014 to February 2023, focusing on Applied Physics and Engineering. Ian S.'s earlier experience includes positions as a Sensor Technologist at TT Electronics Technology and Chief Engineer at Stratophase Ltd, where responsibilities involved the design and development of optical sensors for biotechnology and process control. Ian S. began a career in the tech industry at Nortel Networks as a Product Engineer, involved in the production of Arrayed Waveguide Grating products, and started as a Technology Scholar at Cambridge Consultants. Academically, Ian S. obtained a PhD in Optoelectronics from the University of Southampton, complemented by an MPhys in Physics from the same institution.
LEX Diagnostics
LEX Diagnostics is a medical device company that specializes in molecular diagnostics for primary care. Having solved the PCR cost problem, LEX focuses tightly on nasal and oral samples, and on viral pathogens, to avoid the other high-cost elements of traditional molecular diagnostic products. LEX Diagnostics is a spin-out from TTP plc, atechnology development company in the life science and medical device sector. The origins of the LEX technology lie in an internal R&D project to reduce the time it takes to get a result from a PCR test. It formed a company when it became clear the solution also reduced the cost and size of any diagnostic device using it.LEX Diagnostics was founded in 2020 and is based in Melbourn, United Kingdom.